AmoyDx® HANDLE Melanoma Next Generation Sequencing Panel


The AmoyDx® HANDLE Melanoma NGS Panel is a Next-Generation Sequencing-based assay for the qualitative detection of mutations (SNVs), insertions and deletions (InDels) in nine key genes that play a decisive role in the analysis of malignant melanomas. In addition to the detection of common biomarkers such as BRAF, NRAS, KIT, GNA11 and GNAQ, mutations in two critical hotspot areas of the TERT promoter (C228T, C250T) are also detected